Loxo Oncology (LOXO) Tops Q1 EPS by 60c, Beats on Revenues
Get Alerts LOXO Hot Sheet
Join SI Premium – FREE
Loxo Oncology (NASDAQ: LOXO) reported Q1 EPS of ($0.12), $0.60 better than the analyst estimate of ($0.72). Revenue for the quarter came in at $38.43 million versus the consensus estimate of $16.46 million.
For earnings history and earnings-related data on Loxo Oncology (LOXO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Walgreens Boots Alliance (WBA) Tops Q2 EPS by 38c, Offers Guidance
- VNET Group (VNET) Tops Q4 EPS by 18c, provides guidance
- Verint Systems (VRNT) Tops Q4 EPS by 10c, Offers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!